|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,953.50 DKK | -0.56% |
|
+5.74% | +30.89% |
| 14/11 | Kepler Cheuvreux Kicks Off Genmab Coverage at Hold | MT |
| 11/11 | Fitch Assigns First-time Rating to Genmab with Stable Outlook | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -0.56% | +5.74% | +30.89% | +28.69% | -14.32% | 1.87TCr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition